A timely update of global COVID-19 vaccine development

Linda S. Klavinskis; Margaret A. Liu; Shan Lu

doi:10.1080/22221751.2020.1838246

Emerging Microbes and Infections (Jan 2020)

A timely update of global COVID-19 vaccine development

Linda S. Klavinskis,
Margaret A. Liu,
Shan Lu

Affiliations

Linda S. Klavinskis: Department of Infectious Diseases, King’s College London, London, UK
Margaret A. Liu: ProTherImmune, Lafayette, CA, USA
Shan Lu: Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA

DOI: https://doi.org/10.1080/22221751.2020.1838246
Journal volume & issue: Vol. 9, no. 1
pp. 2379 – 2380

Abstract

Read online

ABSTRACTThis commentary provides an overview and links to presentations of a recent virtual congress series organized by the International Society for Vaccines (ISV) focused on COVID-19 vaccines. The series provided the academic community and vaccine developers as well as the wider general public with balanced information of the global response and resources for COVID-19 vaccines under development featuring: 1) NGOs and the regulatory perspective, 2) the status of vaccine development efforts, and 3) panel discussions to present and discuss challenges. ISV is a non-profit scientific organization whose members work on all areas relevant to vaccines. ISV plans to host additional virtual symposia including regional meetings and incorporating other topics along with COVID-19 vaccines.

Published in Emerging Microbes and Infections

ISSN: 2222-1751 (Online)
Publisher: Taylor & Francis Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Infectious and parasitic diseases; Science: Microbiology
Website: https://www.tandfonline.com/journals/temi

About the journal

Abstract

Keywords